×
We're aware of a cyber security incident affecting the electronic prescriptions provider MediSecure. The eRX Script Exchange (eRX) and the National Prescription Delivery Service (NPDS) continue to operate as usual and have not been impacted. Find out more and read our statement here.

Submission on the National Cervical Screening Program guidelines changes


Last updated 22 December 2021

Summary

Date: 21 December 2021

The RACGP has provided a response to Cancer Council Australia on the National Cervical Screening Program Guidelines changes. The RACGP recommends including relevant information from the guideline when providing a positive result to GPs, clarification of the appropriate clinical management pathway for patients with a human papilloma virus (HPV) positive (non 16/18) self-collected screening test result, and clarification in some of the wording within the document.

Advertising

Advertising